← Eichor
Condition: Mediastinum Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mediastinum Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)
NA · 1 location(s) · Fudan University · NCT04527419Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC
NA · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT04631770Validation of an AI-Assisted Mediastinal EUS System for Training Improvement: a Prospective, Multi-Center, Randomized Tr
NA · 1 location(s) · The Third Xiangya Hospital of Central South University · NCT06790108Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed
Phase 2 · 6 location(s) · Academic and Community Cancer Research United · NCT06238648Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab
Phase 2 · 1 location(s) · Regina Elena Cancer Institute · NCT06771518The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Phase 1/Phase 2 · 11 location(s) · AVM Biotechnology Inc · NCT04329728Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma
Phase 1/Phase 2 · 5 location(s) · Pell Bio-Med Technology Co., Ltd. · NCT05326243CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
Phase 1 · 7 location(s) · British Columbia Cancer Agency · NCT06208735Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT05672251Clinical Impact of Thoracic Scanographic Characteristics of Hematologic Malignancy Patients
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05694806Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE）
NA · 1 location(s) · Ruijin Hospital · NCT07004634CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
Phase 1 · 1 location(s) · Marcela V. Maus, M.D.,Ph.D. · NCT06026319Diagnosis and Comprehensive Treatment of Mediastinal Interventional Technique
Phase N/A · 1 location(s) · Dan Liu · NCT06128681Thoracic Surgery by the Medtronic Hugo™ Robotic System
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT06669104B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Phase 4 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT05518383Phase II Trial of Lung Chemoemobolization
Phase 2 · 2 location(s) · City of Hope Medical Center · NCT05672108Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06464861Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Phase 2 · 77 location(s) · Allogene Therapeutics · NCT06500273Italian Observational Study on CAR-T Therapy for Lymphoma
Phase N/A · 1 location(s) · Paolo Corradini · NCT06339255Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients
Phase 1/Phase 2 · 2 location(s) · Curocell Inc. · NCT04836507DALY II USA/ MB-CART2019.1 for DLBCL
Phase 2 · 32 location(s) · Miltenyi Biomedicine GmbH · NCT04792489A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Ref
Phase 1 · 1 location(s) · GenomeFrontier Therapeutics TW Co., Ltd. · NCT06703892Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Phase 1/Phase 2 · 34 location(s) · Lyell Immunopharma, Inc. · NCT05826535Immunotherapy in Lymphoma
Phase N/A · 2 location(s) · Sung-Soo Park · NCT06796517Clinical Research on a Novel Deep-learning Based System in Mediastinal Endoscopic Ultrasound Scanning
NA · 1 location(s) · The Third Xiangya Hospital of Central South University · NCT05792280Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before C
Phase 2 · 7 location(s) · Mayo Clinic · NCT06834373Amping up With PemJAK
Phase 2 · 1 location(s) · Seda S. Tolu · NCT07283822Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence
Phase N/A · 2 location(s) · Norwegian University of Science and Technology · NCT05739331Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R)
Phase 2 · 1 location(s) · University of Washington · NCT07097363
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.